Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics
Andriana Ι. Papaioannou, Evangelia Fouka, Νikolaos Tzanakis, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 10, pp. 2588-2595
Open Access | Times Cited: 17

Showing 17 citing articles:

Severe Asthma and Active SARS-CoV-2 Infection: Insights into Biologics
Sara Manti, Michela Leotta, F. D’Amico, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 674-674
Open Access
Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma
Hitasha Rupani, William W. Busse, Peter Howarth, et al.
Allergy (2024) Vol. 79, Iss. 10, pp. 2589-2604
Open Access | Times Cited: 3
Biological therapy of severe asthma – Position of Polish Society of Allergology and Polish Society of Respiratory Diseases
Barbara Rogala, Maciej Kupczyk, Grażyna Bochenek, et al.
Alergologia Polska - Polish Journal of Allergology (2023) Vol. 10, Iss. 2, pp. 77-99
Open Access | Times Cited: 5
Key Characteristics of Asthma Patients with COVID-19 Vary Substantially by Age
Brian Kirui, Ailiana Santosa, Huiqi Li, et al.
Journal of Asthma and Allergy (2024) Vol. Volume 17, pp. 589-600
Open Access | Times Cited: 1
The association of preexisting severe asthma with COVID-19 outcomes
Paul Terry, R. Eric Heidel, Rajiv Dhand
Current Opinion in Pulmonary Medicine (2023) Vol. 29, Iss. 3, pp. 215-222
Open Access | Times Cited: 3
The SARS-CoV-2 pandemic and asthma: What we have learned and what is still unknown
Christa McPhee, Kateryna Yevdokimova, Linda Rogers, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 6, pp. 1376-1381
Closed Access | Times Cited: 3
Treating asthma in the time of COVID
Tara F. Carr, Merritt L. Fajt, Monica Kraft, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 4, pp. 809-817
Open Access | Times Cited: 3
Clinical features in patients with COVID-19 treated with biologics for severe asthma
Takanori Numata, Keitaro Okuda, Hanae Miyagawa, et al.
Journal of Allergy and Clinical Immunology Global (2024) Vol. 3, Iss. 2, pp. 100219-100219
Open Access
COVID-19 in patients with airways disease: COPD, asthma and bronchiectasis
Lewis Marshall, Emma Johnson, James D. Chalmers
European Respiratory Society eBooks (2024)
Closed Access
Coronavirus disease 2019 and severe asthma
Alida Benfante, Giuseppe Pirrello, F Sala, et al.
Current Opinion in Allergy and Clinical Immunology (2023) Vol. 23, Iss. 2, pp. 193-198
Closed Access | Times Cited: 1
The Frequency and Severity of COVID-19 in Patients Receiving Biological Agents and Risk Factors: Experience of an Allergy Clinic
Sadan SOYYIGIT, Sengul BEYAZ, Zeynep CELEBI SOZENER
Asthma Allergy Immunology (2023), pp. 35-44
Open Access | Times Cited: 1
Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway disease
Melek Cihanbeylerden, Özge Can Bostan, Gülseren Tuncay, et al.
Allergy and Asthma Proceedings (2023) Vol. 44, Iss. 4, pp. e3-e10
Closed Access | Times Cited: 1
Mepolizumab as a Potential Protective Factor of COVID-19 Mortality: A Case Report of Chronic Bronchitis and Asthma in an Elderly Patient
Sanamveer S. Dhillon, Nimrit K. Toor, Maria E. Ramos‐Niño, et al.
American Journal of Case Reports (2022) Vol. 23
Open Access | Times Cited: 2
Safety of Biologicals In Severe Asthma Patients Having COVID-19
Öner Özdemır
Authorea (Authorea) (2023)
Open Access
Mortality Statistics in Asthma
Rodney C Richie
Journal of Insurance Medicine (2023) Vol. 49, Iss. 4, pp. 244-249
Closed Access
Safety of biologicals in severe asthma patients having COVID‐19
Öner Özdemır
Pediatric Pulmonology (2023) Vol. 58, Iss. 7, pp. 2140-2141
Open Access
How does the pandemic shape the future of allergies?
Nikolaos G. Papadopoulos, Michael Miligkos
BMJ Nutrition Prevention & Health (2023) Vol. 6, Iss. Suppl 3, pp. s2-s7
Open Access
Page 1

Scroll to top